Principle Investigator: Ariel Portera, DO
Co-PI: Michael Choi, MD | Co-I: Melanie Fiorella, MD 
 
This study aims to determine the feasibility of a whole food, plant-based (WFPB) dietary intervention in low-risk patients with CLL. Secondary outcomes explored whether adherence to a WFPB diet was associated with changes in CLL biomarkers and biomarkers and anthropometric measures of cardiometabolic health. The intervention included 8 live cooking classes, and multiple individual sessions with both a dietitian and health coach.